Formula Grant MD2024018

Award Date 8/12/24
Completion Date 5/30/25
Dollars Obligated $6M
Federal Grant Program
20.526
Assistance Type
Formula Grant
Place of Performance
Maryland, USA
Similar Awards
The Federal Transit Formula Grants program (CFDA 20.507), administered by the Federal Transit Administration (FTA), provided a $54,062,500 award to the Maryland Transit Administration (MTA) on September 10, 2024. The funding will be used to purchase 31 replacement buses and 6 metro rail cars, as well as provide construction management for the MTA's fleet and train control replacement project. These activities are expected to keep the MTA's rolling stock in a state of good repair and promote...
This federal Formula Grant award of $5,328,820.00 was granted on August 15, 2024 by the Federal Transit Administration (FTA) under the Buses and Bus Facilities Formula, Competitive, and Low or No Emissions Programs (CFDA 20.526) to the Maryland Transit Administration (MTA). The funding will support the procurement of 16 replacement vehicles, 7 expansion vehicles, 7 automatic vehicle location system devices, and 6 electronic fareboxes for transit services in multiple Maryland counties and...
This $57,190,037 Formula Grant award from the Federal Transit Administration (FTA) under the Federal Transit Formula Grants program (CFDA 20.507) will provide funding to the Maryland Transit Administration (MTA) to support a range of public transportation improvements in Maryland. The grant activities include: Purchasing 77 replacement buses, 3 Metro replacement railcars, and conducting light rail vehicle overhaul work to maintain the MTA's rolling stock fleet in a state of good repair. The...
This $106,758,549 Federal Transit Formula Grant (CFDA 20.507) awarded by the U.S. Department of Transportation's Federal Transit Administration (FTA) to the Maryland Transit Administration (MTA) supports a comprehensive set of capital activities critical to providing transit service across Maryland. Key products and services funded under this award include: The purchase of 11 replacement SUVs, 20 replacement cutaway buses, and 10 metro fleet replacement cars. Additionally, the grant supports...
The Maryland Transit Administration (MTA) was awarded a $111.2 million Project Grant from the Federal Transit Administration's Federal Transit Formula Grants program (CFDA 20.507) to fund transit capital projects and commuter assistance programs from September 2022 through November 2025. Specifically, the grant will fund the purchase of 77 replacement buses and 3 new metro cars to maintain the state's rolling stock in a state of good repair. It will also fund Maryland's annual Commuter...
This $3,273,120 Federal Transit Formula Grant (CFDA 20.507) award from the U.S. Department of Transportation's Federal Transit Administration (FTA) provides funding for capital projects in federally urbanized areas in Maryland. Key activities to be performed include preventative maintenance, procurement of computer equipment, construction of a facility, and mobility management. Expected outcomes include upkeep of facilities and rolling stock, procurement of computer equipment, and improved bus...
The Maryland Transit Administration (MTA) was awarded a $72.7 million Project Grant from the U.S. Department of Transportation's Federal Transit Administration under the Federal Transit Formula Grants program (CFDA 20.507) to support capital and operating assistance for transit services in Maryland from June 2021 through November 2025. The Urbanized Area Formula Funding Program (49 U.S.C. 5307) makes federal resources available to local and regional authorities for transit capital projects,...
This federal Formula Grant award, provided by the U.S. Department of Transportation's Federal Transit Administration (CFDA 20.507 - Federal Transit Formula Grants), awarded $16,745,774 to the Maryland Transit Administration (MTA) on August 30, 2024. The purpose of this grant is to provide funding for operating and technical assistance costs to maintain efficient transit operations across multiple counties in Maryland. Key activities to be performed include maintaining operating standards and...
The Federal Transit Administration (FTA) awarded a $15,083,968 Formula Grant (CFDA 20.507) to the Maryland Transit Administration (MTA) on June 30, 2025. The grant funds will be used to cover eligible preventive maintenance expenses, allowing MTA to meet preventive maintenance standards and continue providing transit operations while keeping vehicles in a state of good repair. The intended beneficiary of this award is MTA and its riders. No sub-award activities were mentioned in the provided...
The Maryland Transit Administration received a $6,834,515 Federal Transit Formula Grant (CFDA 20.507) from the Federal Transit Administration (FTA) to provide funding for capital projects in federally urbanized areas of Maryland. The award supports activities such as preventative maintenance, procurement of rolling stock, design engineering and construction of facilities, and mobility management. Expected outcomes include upkeep of facilities, rolling stock procurement, and improved bus...

The Federal Transit Administration (FTA), under the Buses and Bus Facilities Formula, Competitive, and Low or No Emissions Programs (CFDA 20.526), awarded a $5,961,709 Formula Grant to the Maryland Transit Administration (MTA) on August 12, 2024. The purpose of this grant is to provide capital assistance for the construction of the Kirk Phase II Ultimate Bus Facility and the procurement of replacement buses for MTA's transit system.

The grant funding will enable MTA to promote alternatives to single-occupancy driving and build a new efficient transit facility to ensure reliable service for riders who rely on MTA's bus, metro, light rail, and commuter rail systems across Maryland. This investment in infrastructure and vehicle replacements is expected to enhance public transportation accessibility, safety, and efficiency for MTA and its riders.

Generated 5/13/25, 1:51 AM